BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33323540)

  • 1. Role of FUT8 expression in clinicopathology and patient survival for various malignant tumor types: a systematic review and meta-analysis.
    Ma M; Han G; Wang Y; Zhao Z; Guan F; Li X
    Aging (Albany NY); 2020 Dec; 13(2):2212-2230. PubMed ID: 33323540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer.
    Chen CY; Jan YH; Juan YH; Yang CJ; Huang MS; Yu CJ; Yang PC; Hsiao M; Hsu TL; Wong CH
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):630-5. PubMed ID: 23267084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma.
    Tada K; Ohta M; Hidano S; Watanabe K; Hirashita T; Oshima Y; Fujnaga A; Nakanuma H; Masuda T; Endo Y; Takeuchi Y; Iwashita Y; Kobayashi T; Inomata M
    Surg Today; 2020 Jul; 50(7):767-777. PubMed ID: 31950256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucosyltransferase 8 expression in breast cancer patients: A high throughput tissue microarray analysis.
    Yue L; Han C; Li Z; Li X; Liu D; Liu S; Yu H
    Histol Histopathol; 2016 May; 31(5):547-55. PubMed ID: 26596733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
    Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z
    Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.
    Noda M; Okayama H; Kofunato Y; Chida S; Saito K; Tada T; Ashizawa M; Nakajima T; Aoto K; Kikuchi T; Sakamoto W; Endo H; Fujita S; Saito M; Momma T; Ohki S; Kono K
    PLoS One; 2018; 13(7):e0200315. PubMed ID: 29975776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers.
    Honma R; Kinoshita I; Miyoshi E; Tomaru U; Matsuno Y; Shimizu Y; Takeuchi S; Kobayashi Y; Kaga K; Taniguchi N; Dosaka-Akita H
    Oncology; 2015; 88(5):298-308. PubMed ID: 25572677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosyltransferase 8 is Overexpressed and Influences Clinical Outcomes in Lung Adenocarcinoma Patients.
    Liang Y; Wang T; Gao R; Jia X; Ji T; Shi P; Xue J; Yang A; Chen M; Han P
    Pathol Oncol Res; 2022; 28():1610116. PubMed ID: 35237113
    [No Abstract]   [Full Text] [Related]  

  • 9. MicroRNA-198-5p inhibits the migration and invasion of non-small lung cancer cells by targeting fucosyltransferase 8.
    Wang S; Zhang X; Yang C; Xu S
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):955-967. PubMed ID: 31381176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucosyltransferase 8 regulation and breast cancer suppression by transcription factor activator protein 2γ.
    Ma M; Guo D; Tan Z; Du J; Guan F; Li X
    Cancer Sci; 2021 Aug; 112(8):3190-3204. PubMed ID: 34036684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of trypsinogen expression is associated with growth retardation in alpha1,6-fucosyltransferase-deficient mice: attenuation of proteinase-activated receptor 2 activity.
    Li W; Nakagawa T; Koyama N; Wang X; Jin J; Mizuno-Horikawa Y; Gu J; Miyoshi E; Kato I; Honke K; Taniguchi N; Kondo A
    Glycobiology; 2006 Oct; 16(10):1007-19. PubMed ID: 16861703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.
    Wang X; Chen J; Li QK; Peskoe SB; Zhang B; Choi C; Platz EA; Zhang H
    Glycobiology; 2014 Oct; 24(10):935-44. PubMed ID: 24906821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
    Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
    Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non‑small cell lung cancer.
    Park S; Lim JM; Chun JN; Lee S; Kim TM; Kim DW; Kim SY; Bae DJ; Bae SM; So I; Kim HG; Choi JY; Jeon JH
    Int J Oncol; 2020 Feb; 56(2):559-567. PubMed ID: 31894325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC).
    Li F; Zhao S; Cui Y; Guo T; Qiang J; Xie Q; Yu W; Guo W; Deng W; Gu C; Wu T
    Am J Cancer Res; 2020; 10(3):816-837. PubMed ID: 32266093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.